文献速递慢性静脉疾病静脉血栓栓塞

髂股静脉支架置入治疗血栓后综合征的系统评价与荟萃分析

Systematic Review and Meta-Analysis of Iliofemoral Stenting for Post-thrombotic Syndrome.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2018-11-07

该系统评价与荟萃分析纳入7项研究共489例患者504条肢体,评估髂股静脉支架置入治疗血栓后综合征(PTS)合并髂股静脉梗阻的疗效与安全性。结果显示技术成功率95%,12个月一期通畅率83.36%,但证据质量极低。作者认为静脉支架可作为PTS合并髂股梗阻的治疗选择。

要点

  • 髂股静脉支架置入治疗PTS合并梗阻的技术成功率达95%。
  • 12个月一期、辅助一期和二期通畅率分别为83.36%、90.59%和94.32%。
  • 证据质量极低,支架置入应视为一种治疗选择而非标准推荐。

核心结论

  • 静脉支架置入可能有效且围手术期并发症风险低,但支持该治疗的证据质量极低。
  • 髂股静脉支架置入应被视为PTS合并髂股静脉梗阻的一种治疗选择。

研究设计与样本

  • 系统评价与荟萃分析,检索MEDLINE、EMBASE和Cochrane对照试验中心注册库至2018年1月15日。
  • 纳入7项研究,共489例患者504条肢体。

主要发现

  • 技术成功率为95%。
  • 30天血栓事件、围手术期静脉损伤和背痛的合并发生率分别为3.4%、18.14%和52%。
  • 溃疡愈合率、疼痛缓解率和水肿缓解率分别为75.66%、52%和42%。
  • 12个月一期、辅助一期和二期通畅率分别为83.36%、90.59%和94.32%。
  • 36个月一期、辅助一期和二期通畅率分别为67.98%、82.26%和86.10%。

关键数值与推荐

  • GRADE评估显示11项相关结局的证据质量均为「极低」。

临床怎么用

  • 对于PTS合并髂股静脉梗阻患者,可考虑行髂股静脉支架置入作为治疗选项。
  • 临床决策时应充分告知患者证据质量极低及远期通畅率数据。

局限性

  • 纳入研究数量有限(7项),总样本量489例患者。
  • GRADE评估显示11项相关结局的证据质量均为「极低」。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Stent placements are considered as a treatment for post-thrombotic syndrome (PTS) with iliofemoral obstruction, but the application of these iliofemoral venous stents has also caused a lot of controversy. The purpose of this systematic review and meta-analysis was to summarise the efficacy and safety of venous stents in PTS with obstruction in iliofemoral venous segments. METHODS: MEDLINE, EMBASE, and the Cochrane Central Register for Controlled Trials databases and key references were searched up to 15 January 2018. The main relevant outcomes included technical success, peri-operative complications, symptom resolution, a change of symptom scores, and long-term patency of the stents. RESULTS: Overall, 504 limbs of 489 patients from seven studies were included in this study. A GRADE assessment showed the quality of the evidence was "very low" for 11 relevant outcomes. The technical success rate was 95%. The pooled rate of complications including 30 day thrombotic event, per-operative venous injury, and back pain was 3.4%, 18.14%, and 52%, respectively. The rates of ulcer healing, pain and oedema relief were 75.66%, 52%, and 42%, respectively. The primary, assisted primary and secondary patency rates were 83.36%, 90.59%, and 94.32%, respectively, at 12 months and 67.98%, 82.26%, and 86.10%, respectively, at 36 months. CONCLUSIONS: Endovenous stenting has the potential to be effective and has a low risk of peri-operative complications. The quality of evidence to support this treatment is very low. Endovenous iliofemoral stenting should be considered a treatment option for PTS with iliofemoral obstruction.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Qiu P, Zha B, Xu A, et al. Systematic Review and Meta-Analysis of Iliofemoral Stenting for Post-thrombotic Syndrome. Eur J Vasc Endovasc Surg. 2018. PMID: 30414801. doi:10.1016/j.ejvs.2018.09.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。